In this webinar, we will discuss:
- How to utilize the BioMAP® phenotypic profiling platform to investigate the pharmacodynamic interactions of methotrexate and adalimumab versus Tocilizumab in RA treatment.
- Share results that suggest a systematic evaluation of potential pharmacodynamic interactions can inform on addition or synergistic combination therapy in diseases such as RA.
- Present a powerful approach to investigate combination treatments in vitro while obtaining insight into in vivo behaviour of treatments for improved patient outcomes.
Don't wait to register for the System Investigation of Biologic Effects of Rheumatoid Arthritis Treatments using Phenotypic Profiling. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.
|Conference/Event Dates:||05/18/2016 - 05/18/2016|
|Other Industries:||Clinical Pharmacology, Pharmaceutical, Professional Healthcare|
|Audience:||This webinar is intended for pharmaceutical and biotechnology drug discovery researchers with a key focus on combination therapy development.
VPs and Directors of therapeutic areas
VPs, Directors and Scientists of drug discovery programs
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.